The AJCC TNM staging system has been widely accepted as a powerful predictor of treatment response and survival in gastric cancer, thus it is of interest to test whether the prognostic value of the FEZF1-AS1 is independent of AJCC stage. The gene discussed is FEZF1; the disease is gastric cancer.